About INNOVATIVE NEUROTECHNOLOGIES, INC.
Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company focused on developing disease-modifying biotherapeutics for neurodegenerative tauopathies, including Alzheimer's disease. The company operates in a virtual mode to reduce overhead and efficiently advance projects into clinical development.
Development of disease-modifying biotherapeutics for neurodegenerative tauopathiesCreation of novel recombinant adeno-associated viral (AAV) vectors for CNS delivery of anti-Tau therapiesConducting preliminary 'proof-of-concept' animal efficacy studiesTargeting orphan or niche genetic disorders for FDA fast-track designation
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INNOVATIVE NEUROTECHNOLOGIES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.